NYSE: ARDT · Industrial Applications and Services · 4 alerts · CIK 1756655
Share price
$18.10Close, Nov 16
Market cap
$2.55B
Shares outstanding
140.94MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Services-General Medical & Surgical Hospitals, NECSIC 8062
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Ardent Health, Inc. filings on SEC EDGAR ↗
Ardent Health Signs $47M M&A Deal with Boone Health
Ardent Health (NYSE: ARDT) has entered into a definitive agreement to acquire Boone Health, a Missouri-based not-for-profit health system, for $47 million in cash. The deal includes a 392-bed hospital and 19 sites of care, with Ardent committing an additional $200 million in capital investments over the next 10 years. The transaction is expected to close in Q1 2027 and be 6-8% accretive to Ardent's Adjusted EBITDA by the third year.
For the three months ended September 30, 2026, Ardent Health reported total revenue of $1.62 billion and net income attributable to the company of $44.5 million, a significant recovery from a net loss of $23.5 million in the prior year period. For the nine-month period, net income reached $101.3 million, supported by a decrease in salaries and benefits expenses and the absence of debt extinguishment losses seen in 2025.
Ardent Health reported third quarter 2026 total revenue of $1.62 billion, a 3.1% increase year-over-year, and net income of $45 million. The company raised its full-year 2026 Adjusted EBITDA guidance midpoint by 1.5% based on year-to-date performance and operational momentum from its IMPACT initiatives.
“We delivered strong third quarter results, highlighted by adjusted EBITDA of $138 million, a 4% reduction in SWB expense, and 2.9% adjusted admissions growth. Our performance reflects disciplined execution, with volumes improving sequentially and continued progress on our operating priorities. IMPACT initiatives continued to gain traction and remain on track to achieve at least $70 million of savings this year, contributing to greater efficiency and stronger financial performance.”
Dave Caspers, President and Chief Executive Officer of Ardent Health
“We enter the fourth quarter with confidence in the trajectory of our business and ability to execute on the opportunities ahead. Based on our year-to-date performance and continued operational momentum, we are raising our 2026 Adjusted EBITDA guidance midpoint 1.5%.”
Dave Caspers, President and Chief Executive Officer of Ardent Health
Ardent Health has recharacterized the June 2026 departure of former President and CEO Martin J. Bonick as a termination for 'Cause' following a board review of undisclosed third-party compensation. As a result, the company is discontinuing approximately $4.5 million in remaining cash severance payments and cancelling all of Mr. Bonick's outstanding unvested performance-based restricted stock units.